Yet deletion of Bid does not result in enhanced HCC development induced by diethylnitrosamine (DEN) [12, 19], as it would be predicated from the diminished cell death, but results in diminished HCC development, which may be anticipated based on reduced pro-proliferation effect of Bid [12, 19]. The gene discussed is BID; the disease is hepatocellular carcinoma.